Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q4 2018 · 31 positions · Total reported value $584.51M · Top-10 concentration 58.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.1% · 6 new · 3 cut · 3 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +47.2% · vs SPY +32.4% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2018 13F filing, Casdin Capital disclosed 31 equity positions with a combined reported value of $584.51M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.4% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q4 2018 were LOXO ($50.42M), MYOK ($38.60M), BPMC ($34.50M). By sector, the heaviest allocations are Health Care 34.1%, Industrials 5.8%. Versus the prior quarter, allocation shifted toward Industrials (+1.6pp) and away from Health Care (-1.6pp).

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 3 and fully exited 3, a turnover rate of 26.1% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q4 2018 were IBB ($5.79M), DNLI ($2.07M), QTNT ($1.99M).

Of the 3 positions fully exited versus the prior quarter, the largest were CRSP ($9.76M), OSUR ($8.11M), CLVSQ ($6.90M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2018)

  • IBB ISHARES TR · $5.79M
  • DNLI DENALI THERAPEUTICS INC · $2.07M
  • QTNT QUOTIENT LTD · $1.99M

Fully Exited (vs previous quarter)

  • CRSP CRISPR THERAPEUTICS AG · prev qtr: $9.76M
  • OSUR ORASURE TECHNOLOGIES INC · prev qtr: $8.11M
  • CLVSQ LAS VEGAS SANDS CORP COM · prev qtr: $6.90M
  • NEOG NEOGEN CORP · prev qtr: $4.65M
  • CELG CELGENE CORP · prev qtr: $4.47M
  • GILD GILEAD SCIENCES INC · prev qtr: $3.86M
  • CTMX CYTOMX THERAPEUTICS INC. · prev qtr: $3.84M
  • JNCE JOUNCE THERAPEUTICS INC · prev qtr: $2.44M

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 43 US equity positions with a combined value of $2.00B. HoldingsHub carries 43 quarters of its filings (Q4 2015–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 43 positions · $2.00B reported value (Q2 2026)
  • Top 10 holdings = 77.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 24.2%
  • Average position size: $46.46M

Sector Tilt

  • Health Care 94.2%
  • Industrials 5.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 9 added, 3 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 34.1%
Other 58.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 360.00K $50.42M 8.63%
8.63%
Hold
2 790.00K $38.60M 6.60%
6.60%
Reduce
3 640.00K $34.50M 5.90%
5.90%
Reduce
4 2.02M $33.82M 5.79%
5.79%
Hold
5 840.00K $32.88M 5.62%
5.62%
Add
6 330.00K $32.74M 5.60%
5.60%
Add
7 2.55M $32.72M 5.60%
5.60%
Hold
8 312.00K $29.89M 5.11%
5.11%
Hold
9 2.43M $29.22M 5.00%
5.00%
Hold
10 2.40M $26.54M 4.54%
4.54%
Hold
11 355.00K $25.88M 4.43%
4.43%
Add
12 445.00K $20.52M 3.51%
3.51%
Reduce
13 3.81M $18.54M 3.17%
3.17%
Add
14 860.00K $18.34M 3.14%
3.14%
Add
15 60.00K $18.00M 3.08%
3.08%
Reduce
16 150.00K $16.37M 2.80%
2.80%
Add
17 2.64M $15.07M 2.58%
2.58%
Add
18 350.00K $14.37M 2.46%
2.46%
Reduce
19 1.08M $12.40M 2.12%
2.12%
Reduce
20 720.59K $11.13M 1.91%
1.91%
Hold
21 550.00K $10.97M 1.88%
1.88%
Hold
22 480.00K $10.92M 1.87%
1.87%
Add
23 1.13M $10.60M 1.81%
1.81%
Reduce
24 70.00K $9.82M 1.68%
1.68%
Hold
25 350.00K $7.83M 1.34%
1.34%
Hold
26 1.56M $6.24M 1.07%
1.07%
Add
27 60.00K $5.79M 0.99%
0.99%
New
28 200.00K $5.03M 0.86%
0.86%
Hold
29 100.00K $2.07M 0.35%
0.35%
New
30 325.00K $1.99M 0.34%
0.34%
New
31 263.34K $1.32M 0.23%
0.23%
Reduce

FAQ

What did Casdin Capital buy in 2018-Q4?

In its 2018-Q4 13F filing, Casdin Capital reported 31 equity positions worth $584.51M in aggregate; its largest disclosed positions were LOXO ($50.42M), MYOK ($38.60M), BPMC ($34.50M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $584.51M of long equity holdings across 31 positions as of 2018-Q4. Top-10 holdings account for 58.4% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →